DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

36.14 0.09 (0.25%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ENTA $36.14 0.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.73
Previous Close $36.05
Daily Range $35.10 - $36.16
52-Week Range $30.13 - $52.58
Market Cap $675.1M
P/E Ratio 8.42
Dividend (Yield) $0.00 (0.0%)
Volume 212,892
Average Daily Volume 337,816
Current FY EPS $5.45

Sector

Industry

Enanta Pharmaceuticals, Inc. (ENTA) Description

Enanta Pharmaceuticals, Inc. Website: http://www.enanta.com/

News & Commentary Rss Feed

3 Beaten Down Healthcare Stocks Poised for a Turnaround

They're beaten down, but these 3 healthcare stocks just might be ready to bounce back.

5 Biotechnology Bargains Revisited

Merck Faces Hep C Pricing Dilemma to Counter Gilead, Abbvie

Deutsche Bank: Buy Enanta Pharma And Its Near-Term Upside

Deutsche Bank Initiates Enanta Pharmaceuticals At Buy

Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Operating Margin

Insider Trading Alert - ENTA, JBT And NUVA Traded By Insiders

Barclays Expands Coverge To 7 New Biotech Stocks

UPDATE: Results from AbbVie's Study of VIEKIRA PAK

Results from AbbVie's Study of VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir

Results from AbbVie's Study of VIEKIRA PAK™ (ombitasvir, paritaprevir, ritonavir tablets; dasabuvir tablets) in Chronic Hepat

See More ENTA News...